
TY  - JOUR
AU  - Patriarca, Francesca
AU  - Petrucci, Maria T.
AU  - Bringhen, Sara.
AU  - Baldini, Luca
AU  - Caravita, Tommaso
AU  - Corradini, Paolo
AU  - Corso, Alessandro
AU  - Di Raimondo, Francesco
AU  - Falcone, Antonietta
AU  - Ferrara, Felicetto
AU  - Morabito, Fortunato
AU  - Musto, Pellegrino
AU  - Offidani, Massimo
AU  - Petrini, Mario
AU  - Rizzi, Rita
AU  - Semenzato, Gianpietro
AU  - Tosi, Patrizia
AU  - Vacca, Angelo
AU  - Cavo, Michele
AU  - Boccadoro, Mario
AU  - Palumbo, Antonio
TI  - Considerations in the treatment of multiple myeloma: a consensus statement from Italian experts
JO  - European Journal of Haematology
VL  - 82
IS  - 2
SN  - 0902-4441
UR  - https://doi.org/10.1111/j.1600-0609.2008.01179.x
DO  - doi:10.1111/j.1600-0609.2008.01179.x
SP  - 93
EP  - 105
KW  - myeloma
KW  - clinical practice guidelines
KW  - chemotherapy
KW  - transplantation
PY  - 2009
AB  - Abstract Purpose and basic procedure of the study:? The availability of new targeted therapies has revolutionised the treatment of multiple myeloma (MM), for both the newly diagnosed and the relapsed and refractory settings. A panel of Italian experts provided guidelines for optimal clinical practice in the treatment of MM. Main findings and conclusions:? The panel recommended that treatment should only be initiated in symptomatic patients. Autologous stem cell transplantation (ASCT) with melphalan is the treatment of choice in patients younger than 65?yr, and induction therapy including new drugs seems the most suitable preparatory regimen before ASCT. In patients who fail to achieve at least a very good partial response (VGPR) after transplant, a consolidation with a second transplant is of clinical benefit. Also, there is evidence that maintenance with thalidomide after ASCT in young patients failing to reach at least VGPR could prolong survival. In elderly patients, the combination of an alkylating drug with a novel agent should be considered as standard approach. Relapsed MM should be retreated after the reappearance of symptoms and signs of organ and tissue damage. Salvage regimens should include corticosteroids plus bortezomib, thalidomide or lenalidomide.
ER  - 

TY  - JOUR
AU  - Romani, Claudio
AU  - Pettinau, Martina
AU  - Dessalvi, Paolo
AU  - Murru, Roberta
AU  - Angelucci, Emanuele
TI  - Unexpected CNS localization in M2 acute myeloid leukemia: A link with past heroin addiction?
JO  - American Journal of Hematology
JA  - Am. J. Hematol.
VL  - 83
IS  - 8
SN  - 0361-8609
UR  - https://doi.org/10.1002/ajh.21190
DO  - doi:10.1002/ajh.21190
SP  - 682
EP  - 683
PY  - 2008
ER  - 

TY  - JOUR
AU  - D'arena, Giovanni
AU  - Scalzulli, Potito Rosario
AU  - Nobile, Michele
AU  - Dell'olio, Matteo
AU  - Rossi, Giovanni
AU  - Cascavilla, Nicola
TI  - Attenuated doses of rituximab for the treatment of adults with autoimmune cytopenias
JO  - American Journal of Hematology
JA  - Am. J. Hematol.
VL  - 83
IS  - 8
SN  - 0361-8609
UR  - https://doi.org/10.1002/ajh.21203
DO  - doi:10.1002/ajh.21203
SP  - 686
EP  - 687
PY  - 2008
ER  - 

C7  - pp. 43-67
TI  - Blood Donor Medical Assessment and Blood Collection
SN  - 9781444337051
UR  - https://doi.org/10.1002/9781444398748.ch4
DO  - doi:10.1002/9781444398748.ch4
SP  - 43-67
KW  - blood donor assessment
KW  - blood collection, FDA guidelines
KW  - whole blood donors
KW  - medical assessment
KW  - safe blood strategies
KW  - medical history, donor selection
KW  - hereditary hemochromatosis
KW  - donor arm preparation
KW  - apheresis donors
KW  - adverse reactions, in donors
PY  - 2008
AB  - Summary This chapter contains sections titled: Medical assessment of whole blood donors Collection of whole blood Postdonation care and adverse reactions to blood donation Therapeutic bleeding Medical assessment of apheresis donors Adverse reactions in apheresis donors References
ER  - 

AU  - Reese, Jeff
AU  - Dey, S.K.
TI  - Cyclooxygenases
SN  - 9780471374947
UR  - https://doi.org/10.1002/0471203076.emm0805.pub2
DO  - doi:10.1002/0471203076.emm0805.pub2
KW  - cyclooxygenases
PY  - 2008
ER  - 

TY  - JOUR
C7  - e12328
TI  - IXA 2017- Abstracts of the 14th Congress of the International Xenotransplantation Association, Baltimore, USA
JO  - Xenotransplantation
JA  - Xenotransplantation
VL  - 24
IS  - 5
SN  - 9780471374947
UR  - https://doi.org/10.1111/xen.12328
DO  - doi:10.1111/xen.12328
SP  - e12328
PY  - 2017
ER  - 

TY  - JOUR
AU  - Rubinstein, Paul G.
AU  - Chen, Yi-Hsiang
TI  - Delayed hemolysis after intravenous anti-D immune globulin infusion in a patient with idiopathic thrombocytopenic purpura
JO  - American Journal of Hematology
JA  - Am. J. Hematol.
VL  - 83
IS  - 8
SN  - 9780471374947
UR  - https://doi.org/10.1002/ajh.21201
DO  - doi:10.1002/ajh.21201
SP  - 684
EP  - 685
PY  - 2008
ER  - 

TY  - JOUR
AU  - Siu, Joey
AU  - McCall, John
AU  - Connor, Saxon
TI  - Systematic review of pathophysiological changes following hepatic resection
JO  - HPB
JA  - HPB
VL  - 16
IS  - 5
SN  - 9780471374947
UR  - https://doi.org/10.1111/hpb.12164
DO  - doi:10.1111/hpb.12164
SP  - 407
EP  - 421
PY  - 2014
AB  - Abstract Objectives Major hepatic resection is now performed frequently and with relative safety, but is accompanied by significant pathophysiological changes. The aim of this review is to describe these changes along with interventions that may help reduce the risk for adverse outcomes after major hepatic resection. Methods The MEDLINE, EMBASE and CENTRAL databases were searched for relevant literature published from January 2000 to December 2011. Broad subject headings were ?hepatectomy/?, ?liver function/?, ?liver failure/? and ?physiology/?. Results Predictable changes in blood biochemistry and coagulation occur following major hepatic resection and alterations from the expected path indicate a complicated course. Susceptibility to sepsis, functional renal impairment, and altered energy metabolism are important sequelae of post-resection liver failure. Conclusions The pathophysiology of post-resection liver failure is difficult to reverse and thus strategies aimed at prevention are key to reducing morbidity and mortality after liver surgery.
ER  - 

TY  - JOUR
AU  - Halfdanarson, Thorvardur R.
AU  - Walker, James A.
AU  - Litzow, Mark R.
AU  - Hanson, Curtis A.
TI  - Severe vitamin B12 deficiency resulting in pancytopenia, splenomegaly and leukoerythroblastosis
JO  - European Journal of Haematology
VL  - 80
IS  - 5
SN  - 9780471374947
UR  - https://doi.org/10.1111/j.1600-0609.2008.01043.x
DO  - doi:10.1111/j.1600-0609.2008.01043.x
SP  - 448
EP  - 451
KW  - B12 deficiency
KW  - pernicious anemia
KW  - pancytopenia
KW  - splenomegaly
KW  - leukoerythroblastosis
PY  - 2008
AB  - Abstract Deficiency of vitamin B12 is a well known cause of megaloblastic anemia and pancytopenia. Splenomegaly and leukoerythroblastosis are much less well known manifestations of B12 deficiency. We report a B12 deficient female with severe pancytopenia including normocytic anemia who also had enlarged spleen and circulating nucleated red blood cells as well as circulating immature myeloid cells. Although these findings are reported in the earlier literature, more modern reviews of the subject often fail to mention this association. We review the literature on these unusual manifestations of B12 deficiency and remind clinicians that splenomegaly and erythroblastosis can serve as diagnostic clues in cases of severe megaloblastic anemia secondary to B12 deficiency.
ER  - 

TY  - JOUR
AU  - Holtan, Shernan G.
AU  - Porrata, Luis F.
AU  - Colgan, Joseph P.
AU  - Zent, Clive S.
AU  - Habermann, Thomas M.
AU  - Markovic, Svetomir N.
TI  - mTOR inhibitor monotherapy is insufficient to suppress viremia and disease progression in Epstein-Barr virus-driven lymphoproliferative disorders (EBV-LPD)
JO  - American Journal of Hematology
JA  - Am. J. Hematol.
VL  - 83
IS  - 8
SN  - 9780471374947
UR  - https://doi.org/10.1002/ajh.21216
DO  - doi:10.1002/ajh.21216
SP  - 688
EP  - 689
PY  - 2008
ER  - 

TY  - JOUR
AU  - Comondore, Vikram
AU  - Patterson, A. Caroline
AU  - Zypchen, Leslie
AU  - Dalal, Bakul
TI  - Pure red cell aplasia in a patient with adult-onset Still's disease
JO  - American Journal of Hematology
JA  - Am. J. Hematol.
VL  - 83
IS  - 8
SN  - 9780471374947
UR  - https://doi.org/10.1002/ajh.21209
DO  - doi:10.1002/ajh.21209
SP  - 687
EP  - 688
PY  - 2008
ER  - 

TY  - JOUR
AU  - Wehbe, Edgard
AU  - Moore, Thomas A.
TI  - Cold agglutinin-associated hemolytic anemia due to brucellosis: First case report
JO  - American Journal of Hematology
JA  - Am. J. Hematol.
VL  - 83
IS  - 8
SN  - 9780471374947
UR  - https://doi.org/10.1002/ajh.21210
DO  - doi:10.1002/ajh.21210
SP  - 685
EP  - 686
PY  - 2008
ER  - 

TY  - JOUR
AU  - Laga, Alvaro
AU  - Kurtis, Jonathan
AU  - Sweeney, Joseph
TI  - Recurrent transfusion-related acute lung injury after fresh frozen plasma in a patient with hereditary factor V deficiency
JO  - American Journal of Hematology
JA  - Am. J. Hematol.
VL  - 83
IS  - 8
SN  - 9780471374947
UR  - https://doi.org/10.1002/ajh.21164
DO  - doi:10.1002/ajh.21164
SP  - 680
EP  - 680
PY  - 2008
ER  - 

TY  - JOUR
AU  - Zlotnick, David M.
AU  - Merrens, Edward J.
AU  - Petras, Melissa L.
AU  - Tsongalis, Gregory J.
AU  - Bentley, Heather
AU  - Fingar, Elizabeth L.
AU  - Levy, Norman B.
TI  - Intravascular lymphoma as a recurrence of testicular Non-Hodgkin's lymphoma confirmed by polymerase chain reaction
JO  - American Journal of Hematology
JA  - Am. J. Hematol.
VL  - 83
IS  - 8
SN  - 9780471374947
UR  - https://doi.org/10.1002/ajh.21193
DO  - doi:10.1002/ajh.21193
SP  - 681
EP  - 682
PY  - 2008
ER  - 

TY  - JOUR
TI  - ASBMR 29th Annual Meeting
JO  - Journal of Bone and Mineral Research
JA  - J Bone Miner Res
VL  - 22
IS  - S1
SN  - 9780471374947
UR  - https://doi.org/10.1002/jbmr.5650221406
DO  - doi:10.1002/jbmr.5650221406
SP  - s202
EP  - s251
PY  - 2007
ER  - 

TY  - JOUR
AU  - Miura, Yuji
AU  - Kami, Masahiro
AU  - Yamada, Masatoshi
AU  - Nagamatsu, Soichiro
AU  - Matsumura, Tomoko
AU  - Kodama, Yuko
AU  - Ishida, Yasuo
AU  - Komatsu, Tsunehiko
TI  - Rapid diffuse alveolar hemorrhage associated with all-trans-retinoic acid and filgrastim
JO  - American Journal of Hematology
JA  - Am. J. Hematol.
VL  - 83
IS  - 8
SN  - 9780471374947
UR  - https://doi.org/10.1002/ajh.21194
DO  - doi:10.1002/ajh.21194
SP  - 683
EP  - 683
PY  - 2008
ER  - 

TY  - JOUR
AU  - Candoni, Anna
AU  - Simeone, Erica
AU  - Fanin, Renato
TI  - Extramedullary progression of multiple myeloma under thalidomide therapy despite concomitant response of medullary disease
JO  - American Journal of Hematology
JA  - Am. J. Hematol.
VL  - 83
IS  - 8
SN  - 9780471374947
UR  - https://doi.org/10.1002/ajh.21195
DO  - doi:10.1002/ajh.21195
SP  - 680
EP  - 681
PY  - 2008
ER  - 

C7  - pp. 61-127
TI  - Central Nervous System
SN  - 9780813817538
UR  - https://doi.org/10.1002/9780470344590.ch2
DO  - doi:10.1002/9780470344590.ch2
SP  - 61-127
KW  - nervous system
KW  - postoperative
KW  - neuromuscular
KW  - lidocaine
KW  - salsolinol
PY  - 2008
AB  - Summary This chapter contains section titled: Autonomic Nervous System Peripheral Nervous System and Neuromuscular Function Cerebral Cortex and Cerebral Hemispheres Brainstem, Spinal Cord, and Peripheral Nervous System Special Senses Special Senses: Non-Ophthalmic
ER  - 

TY  - JOUR
AU  - Colditz, Michael J
AU  - Lai, Melissa M
AU  - Cartwright, David W
AU  - Colditz, Paul B
TI  - Subgaleal haemorrhage in the newborn: A call for early diagnosis and aggressive management
JO  - Journal of Paediatrics and Child Health
JA  - J Paediatr Child Health
VL  - 51
IS  - 2
SN  - 9780813817538
UR  - https://doi.org/10.1111/jpc.12698
DO  - doi:10.1111/jpc.12698
SP  - 140
EP  - 146
KW  - delivery
KW  - infant
KW  - newborn
KW  - perinatal mortality
KW  - subgaleal haemorrhage
KW  - vacuum extraction
PY  - 2015
AB  - Abstract Subgaleal haemorrhage (SGH) is an important cause of preventable morbidity and mortality in the neonate. Its increased prevalence in recent years has coincided with the rise in the number of births assisted by vacuum extraction. Three deaths in Australia within the last 7 years have been the subject of two coronial inquests. Subsequent coronial reports have highlighted that neonatal death from SGH can be prevented if appropriate attention is paid to identification of risk factors, early diagnosis, close observation and aggressive treatment. To prevent unnecessary deaths, all involved in the care of the baby after birth need to be aware of the importance of prompt diagnosis, monitoring and early treatment of SGH.
ER  - 

TY  - JOUR
TI  - Dublin Pathology 2015. 8th Joint Meeting of the British Division of the International Academy of Pathology and the Pathological Society of Great Britain & Ireland
JO  - The Journal of Pathology
JA  - J. Pathol.
VL  - 237
IS  - S1
SN  - 9780813817538
UR  - https://doi.org/10.1002/path.4631
DO  - doi:10.1002/path.4631
SP  - S1
EP  - S52
PY  - 2015
ER  - 
